Evidence map›Paper›PMID 41368075›Full record

ArticleHemaSphere2025

The role of time to first progression and fitness status in elderly patients with mantle cell lymphoma: Results from the ELDERLY MANTLE-FIRST study.

Francesca Maria Quaglia, Annalisa Arcari, Lucia Morello, Luigi Marcheselli, Alessandra Tucci, Chiara Pagani, Valentina Bozzoli, Greta Scapinello, Francesco Piazza, Vittorio Ruggero Zilioli and 21 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in HemaSphere, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Francesca Maria QuagliaUOC di Ematologia, DAI Medico Generale AOUI Verona Italy.ORCID https://orcid.org/0000-0003-4347-3775
Annalisa ArcariHematology Unit Ospedale Guglielmo da Saliceto Piacenza Italy.
Lucia MorelloHematology Unit Ospedale Guglielmo da Saliceto Piacenza Italy.
Luigi MarcheselliFondazione Italiana Linfomi Modena Italy.
Alessandra TucciHematology Division ASST Spedali Civili Brescia Brescia Italy.
Chiara PaganiHematology Division ASST Spedali Civili Brescia Brescia Italy.
Valentina BozzoliHematology, P.O.V. Fazzi Lecce Italy.
Greta ScapinelloDepartment of Medicine, Division of Hematology University of Padova Padova Italy.
Francesco PiazzaDepartment of Medicine, Division of Hematology University of Padova Padova Italy.ORCID https://orcid.org/0000-0002-2831-623X
Vittorio Ruggero ZilioliDivision of Hematology ASST Grande Ospedale Metropolitano Niguarda Milan Italy.ORCID https://orcid.org/0000-0001-6915-2246
Cristina MuziDivision of Hematology ASST Grande Ospedale Metropolitano Niguarda Milan Italy.
Benedetta PucciniHaematology Unit Careggi University Hospital Firenze Italy.
Benedetta SordiHaematology Unit Careggi University Hospital Firenze Italy.
Maria Chiara TisiCell Therapy and Hematology San Bortolo Hospital Vicenza Italy.
Nicolò RampiDepartment of Oncology and Hemato-Oncology University of Milan Milan Italy.
Alessia CastellinoDepartment of Hematology Santa Croce e Carle Hospital Cuneo Italy.
Sara Veronica UsaiAO Brotzu-Ospedale Oncologico Businco Unit of Hematology and Bone Marrow Transplant Cagliari Italy.
Jari PaternosterHematology and Bone Marrow Transplant Unit, Section of Biomedicine of Innovation, Department of Engineering for Innovative Medicine (DIMI) University of Verona Italy.
Emanuele CenciniUnit of Hematology Azienda Ospedaliera Universitaria Senese and University of Siena Siena Italy.
Simone FerreroDivision of Hematology, Department of Molecular Biotechnologies and Health Sciences University of Torino Torino Italy.
Chiara ConsoliDivision of Hematology, Department of Molecular Biotechnologies and Health Sciences University of Torino Torino Italy.
Marco BassoOncohematology Unit Veneto Institute of Oncology IOV-IRCCS Padua Italy.
Elisa LucchiniUCO Ematologia Azienda Sanitaria Universitaria Giuliano-Isontina Trieste Italy.
Elsa PenneseHematology Unit, Department of Oncology and Hematology Spirito Santo Hospital Pescara Italy.
Maria Elena NizzoliDivision of Hematology Azienda Unità Sanitaria Locale-IRCCS Reggio Emilia Italy.
Michele SpinaDivision of Medical Oncology and Immune-Related Tumors Centro di Riferimento Oncologico di Aviano IRCCS Aviano Italy.
Luca PezzulloHematology and Transplant Center University Hospital "San Giovanni di Dio e Ruggi d'Aragona" Salerno Italy.
Maria Stella De CandiaHematology Unit IRCCS Istituto Tumori "Giovanni Paolo II" Bari Italy.
Rita TavarozziSC Ematologia Azienda Ospedaliera Santi Antonio e Biagio e Cesare Arrigo Alessandria Italy.ORCID https://orcid.org/0000-0003-3696-7806
Mauro KramperaUOC di Ematologia, DAI Medico Generale AOUI Verona Italy.
Carlo ViscoUOC di Ematologia, DAI Medico Generale AOUI Verona Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41368075
PMCPMC12683294

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.